Debt AdvisoryHealthcareSIGNED
CE-Ventures Backs Aptadir Therapeutics in €40 Million Seed Round, One of Europe’s Largest in Biotech
Value
€40M
Acquirer
CE-Ventures
Target
Aptadir Therapeutics
CE-Ventures, the corporate venture capital arm of Crescent Enterprises, has invested in Aptadir Therapeutics through a €40 million seed round. This funding supports the development of Aptadir Therapeutics, marking one of Europe's largest biotech seed rounds.
The Meridian Weekly
The week's largest deals and the Iberian ones, every Monday. Free.